Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients

In conclusions, age and sarcopenia were critical risk factors for the failure of 6 months of adjuvant chemotherapy. Among elderly patients, sarcopenia can predict the poor success rate of AC.PMID:37648468 | DOI:10.5582/bst.2023.01209
Source: BioScience Trends - Category: Biomedical Science Authors: Source Type: research